Northern Trust Corp Eton Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 59,849 shares of ETON stock, worth $339,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,849

Previous 61,130 2.1%

Holding current value

$339,942

Previous $229,000 14.41%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.06 - $3.75 $3,919 - $4,803	-1,281 Reduced 2.1%	59,849 $196,000
Q1 2024 May 14, 2024	SELL	$3.48 - $5.03 $12,040 - $17,403	-3,460 Reduced 5.36%	61,130 $229,000
Q4 2023 Feb 13, 2024	BUY	$3.45 - $4.66 $93,436 - $126,206	27,083 Added 72.21%	64,590 $282,000
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.63 $11,638 - $25,695	4,564 Added 13.85%	37,507 $156,000
Q2 2023 Aug 11, 2023	SELL	$3.32 - $4.04 $488 - $593	-147 Reduced 0.44%	32,943 $114,000
Q1 2023 May 15, 2023	BUY	$2.89 - $4.1 $7,904 - $11,213	2,735 Added 9.01%	33,090 $127,000
Q2 2021 Aug 13, 2021	SELL	$5.71 - $8.85 $842,813 - $1.31 Million	-147,603 Reduced 82.94%	30,355 $187,000
Q1 2021 May 12, 2021	SELL	$6.93 - $10.07 $39,279 - $57,076	-5,668 Reduced 3.09%	177,958 $1.3 Million
Q4 2020 Feb 11, 2021	BUY	$6.65 - $8.83 $119,354 - $158,480	17,948 Added 10.83%	183,626 $1.49 Million
Q3 2020 Nov 16, 2020	BUY	$4.96 - $9.06 $546,780 - $998,756	110,238 Added 198.84%	165,678 $1.31 Million
Q2 2020 Aug 14, 2020	BUY	$3.5 - $6.09 $119,164 - $207,346	34,047 Added 159.15%	55,440 $302,000
Q3 2019 Nov 13, 2019	BUY	$5.19 - $8.72 $111,029 - $186,546	21,393 New	21,393 $135,000

Others Institutions Holding ETON

# of Institutions

Shares Held

8.16M

Call Options Held

41K

Put Options Held

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $144M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Eton Pharmaceuticals, Inc. Transaction History